粒子線治療の世界市場レポート 2025年

粒子線治療市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR12.4％で21億9,000万米ドルに成長します。予測期間の成長は、医療費の増加、がん以外の新たなアプリケーション、老人人口の増加、ヘルスケアインフラ開発、AIとデータ分析の統合に起因すると考えられます。予測期間の主な動向には、粒子加速器技術の進歩、低分割技術、陽子線と炭素イオンの併用療法、患者の快適性の向上、生物学主導の治療プロトコルなどがあります。

がん罹患率の増加は、今後の粒子線治療市場の成長を牽引すると予想されます。がんは、体内の細胞の異常な増殖や増殖を特徴とする複雑で多様な疾患群です。粒子線治療は、正電荷を帯びた粒子（陽子）を高速に加速して腫瘍に集中させ、正確な放射線を照射することで効果的にがんを治療します。例えば、2024年4月、フランスに本部を置く政府間機関である国際がん研究機関（IARC）は、2022年に約2,000万人のがん患者が新たに発生し、約1,000万人が死亡したと報告しました。人口動態の動向に基づく予測によれば、2050年までに新規がん罹患者の年間発生率は3,500万人に達し、2022年の数字から77％増加する可能性があります。したがって、がん罹患率の上昇は粒子線治療市場の成長を促進する重要な要因です。

高齢化人口の増加は、今後数年間の粒子線治療市場の成長に寄与すると予測されています。高齢化とは、社会における高齢者の割合の増加を特徴とする人口動態の変化を指します。粒子線治療は、がん治療に対する正確で的を絞ったアプローチを提供し、周囲の健康な組織へのダメージを最小限に抑え、長期的な副作用のリスクを低減することで、がん治療を受ける高齢患者の生活の質を高めるため、特に高齢者にとって有益です。例えば、ケニアに本部を置く非営利団体人口問題研究所は2024年1月、65歳以上のアメリカ人の数が2022年の5,800万人から2050年には8,200万人になり、47％増加すると推定しています。この年齢層が総人口に占める割合も、同じ期間に17％から23％に増加すると予想されています。このように、高齢化は粒子線治療市場の重要な促進要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の粒子線治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の粒子線治療市場：成長率分析
• 世界の粒子線治療市場の実績：規模と成長, 2019-2024
• 世界の粒子線治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界の粒子線治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の粒子線治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 陽子線治療
• 重粒子線治療
• 世界の粒子線治療市場：システム別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シングルルームシステム
• マルチルームシステム
• 世界の粒子線治療市場：がんタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小児がん
• 前立腺がん
• 肺がん
• 乳がん
• 脳と脊髄のがん
• その他のがんタイプ
• 世界の粒子線治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 学術研究センター
• 世界の粒子線治療市場、タイプ別サブセグメンテーション：陽子線治療、実績と予測, 2019-2024, 2024-2029F, 2034F
• ペンシルビーム走査型陽子線治療
• 受動散乱陽子線治療
• 強度変調陽子線治療（IMPT）
• 世界の粒子線治療市場、タイプ別サブセグメンテーション：重粒子線治療、実績と予測, 2019-2024, 2024-2029F, 2034F
• 炭素イオン療法
• ヘリウムイオン療法
• その他の重イオン

第7章 地域別・国別分析

• 世界の粒子線治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の粒子線治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 粒子線治療市場：競合情勢
• 粒子線治療市場：企業プロファイル
  • Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Mitsubishi Electric Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips N.V Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sumitomo Heavy Industries Ltd.
• Varian Medical Systems Inc.
• Elekta AB
• Shinva Medical Instrument Co. Ltd.
• Toshiba Medical Systems Corporation
• Brainlab AG
• Accuray Incorporated
• IBA Worldwide
• Mevion Medical Systems Inc.
• Avante Health Solutions
• Provision Healthcare LLC
• ViewRay
• Panacea Biotec Ltd.
• PTW Freiburg GmbH.
• ProNova Solutions LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 粒子線治療市場2029：新たな機会を提供する国
• 粒子線治療市場2029：新たな機会を提供するセグメント
• 粒子線治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Particle therapy is an advanced cancer treatment that employs charged particles, such as protons or heavier ions, to administer radiation therapy directly to cancerous tumors. This method primarily targets energetic ionizing particles at the tumor location, aiming to improve treatment outcomes for patients with various types of tumors, particularly those that are difficult to treat using conventional radiation therapy.

Two primary types of therapies fall under the umbrella of particle therapy, proton therapy and heavy ion therapy. Proton therapy is a specialized form of radiation therapy employed in cancer treatment. It encompasses both single-room systems and multi-room systems, providing versatility in its application. Proton therapy is utilized for the treatment of various cancers, including but not limited to pediatric cancer, prostate cancer, lung cancer, breast cancer, and cancers affecting the brain and spinal cord. The primary end users of particle therapy are hospitals, academic institutions, and research centers. Particle therapy offers a targeted and precise approach to cancer treatment, minimizing damage to surrounding healthy tissues and enhancing the therapeutic effectiveness of radiation.

The particle therapy market research report is one of a series of new reports from The Business Research Company that provides particle therapy market statistics, including particle therapy industry global market size, regional shares, competitors with a particle therapy market share, detailed particle therapy market segments, market trends and opportunities, and any further data you may need to thrive in the particle therapy industry. This particle therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The particle therapy market size has grown rapidly in recent years. It will grow from $1.23 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to clinical research and studies, increased cancer incidence, government support and funding, industry collaboration, and improvements in treatment planning

The particle therapy market size is expected to see rapid growth in the next few years. It will grow to $2.19 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to increasing healthcare expenditure, emerging applications beyond cancer, a rise in the geriatric population, healthcare infrastructure development, AI and data analytics integration. Major trends in the forecast period include advancements in particle accelerator technology, hypofractionation techniques, proton and carbon ion combination therapy, improved patient comfort, and biology-driven treatment protocols.

The increasing prevalence of cancer is anticipated to drive the growth of the particle therapy market in the future. Cancer is a complex and varied group of diseases marked by the abnormal growth and multiplication of cells in the body. Particle therapy effectively treats cancer through precise radiation delivery, utilizing positively charged particles (protons) that are accelerated to high speeds and focused on the tumor. For instance, in April 2024, the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency, reported that nearly 20 million new cancer cases were recorded in 2022, resulting in almost 10 million deaths. Projections based on demographic trends indicate that the annual incidence of new cancer cases could reach 35 million by 2050, representing a 77% increase from the 2022 figures. Therefore, the rising prevalence of cancer is a key factor driving the growth of the particle therapy market.

The increasing aging population is projected to contribute to the growth of the particle therapy market in the coming years. An aging population refers to a demographic shift characterized by a growing proportion of elderly individuals within a society. Particle therapy is particularly beneficial for the geriatric population as it offers a precise and targeted approach to cancer treatment, minimizing damage to surrounding healthy tissues and reducing the risk of long-term side effects, thereby enhancing the quality of life for older patients receiving cancer therapy. For example, in January 2024, the Population Reference Bureau, a Kenya-based nonprofit organization, estimated that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. This age group's share of the total population is also expected to grow from 17% to 23% during the same period. Thus, the aging population is a significant driver of the particle therapy market.

Advanced particle therapy platforms are becoming a significant trend in the particle therapy market. Key players in this field are focusing on developing innovative particle therapy solutions to maintain their competitive edge. For example, in July 2023, RaySearch Laboratories, a Sweden-based medical technology firm, introduced RayStation 2023B. This comprehensive oncology treatment planning system incorporates several groundbreaking advancements in particle therapy, including support for discrete proton arcs and robust optimization based on linear energy transfer (LET). LET optimization aims to minimize potential side effects by reducing LET in at-risk organs while directing high LET particles to tumors for better tumor control. Additionally, discrete proton arc optimization allows for a wider range of beam angles, resulting in more conformal dose distributions and less exposure for sensitive organs. The software also offers easy conversion to standard pencil-beam scanning plans, automatic field-in-field planning for photon treatments, point-based optimization for brachytherapy, and improved data loading speeds.

Key companies in the particle therapy market are intensifying their efforts to develop innovative therapies, with a particular focus on proton therapy solutions, to gain a competitive advantage. Proton therapy technology, a sophisticated form of cancer treatment utilizing protons and positively charged particles, delivers precise and targeted radiation to cancer cells. For instance, in April 2023, P-Cure, an Israel-based high-med-tech company, obtained clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution, allowing sales in the USA. This affordable proton therapy technology is designed for targeted cancer treatment with significantly reduced treatment-related side effects. P-Cure's innovative upright solution, the world's first FDA-approved methodology for patient positioning, enables seated treatment, enhancing both patient comfort and clinical outcomes.

In May 2022, Brainlab AG, a Germany-based medical technology company, acquired a majority stake in medPhoton GmbH for an undisclosed amount. This strategic acquisition aims to expand Brainlab's intraoperative imaging portfolio, drive business growth, bolster product development, and accelerate innovation in the critical field of medical technology. medPhoton GmbH, an Austria-based medical equipment manufacturing company, specializes in providing particle therapy devices and services.

Major companies operating in the particle therapy market include Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy plc, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.

North America was the largest region in the particle therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the particle therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The particle therapy market includes of revenues earned by entities by providing particle therapy services such as treatment planning, particle beam delivery, imaging and simulation, treatment sessions, patient monitoring, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Particle Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on particle therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for particle therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The particle therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Proton Therapy; Heavy Ion Therapy
• 2) By System: Single-Room Systems; Multi-Room Systems
• 3) By Cancer Type: Pediatric Cancer; Prostate Cancer; Lung Cancer; Breast Cancer; Brain And Spinal Cord Cancer; Other Cancer Types
• 4) By End-User: Hospital; Academic And Research Centers
• Subsegments:
• 1) By Proton Therapy: Pencil Beam Scanning Proton Therapy; Passive Scattering Proton Therapy; Intensity-Modulated Proton Therapy (IMPT)
• 2) By Heavy Ion Therapy: Carbon Ion Therapy; Helium Ion Therapy; Other Heavy Ions
• Companies Mentioned: Hitachi Ltd.; Mitsubishi Electric Corporation; Siemens Healthineers AG; Koninklijke Philips N.V; GE Healthcare
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Particle Therapy Market Characteristics

3. Particle Therapy Market Trends And Strategies

4. Particle Therapy Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Particle Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Particle Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Particle Therapy Market Growth Rate Analysis
• 5.4. Global Particle Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Particle Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Particle Therapy Total Addressable Market (TAM)

6. Particle Therapy Market Segmentation

• 6.1. Global Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proton Therapy
• Heavy Ion Therapy
• 6.2. Global Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Room Systems
• Multi-Room Systems
• 6.3. Global Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric Cancer
• Prostate Cancer
• Lung Cancer
• Breast Cancer
• Brain And Spinal Cord Cancer
• Other Cancer Types
• 6.4. Global Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Academic And Research Centers
• 6.5. Global Particle Therapy Market, Sub-Segmentation Of Proton Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pencil Beam Scanning Proton Therapy
• Passive Scattering Proton Therapy
• Intensity-Modulated Proton Therapy (IMPT)
• 6.6. Global Particle Therapy Market, Sub-Segmentation Of Heavy Ion Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carbon Ion Therapy
• Helium Ion Therapy
• Other Heavy Ions

7. Particle Therapy Market Regional And Country Analysis

• 7.1. Global Particle Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Particle Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Particle Therapy Market

• 8.1. Asia-Pacific Particle Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Particle Therapy Market

• 9.1. China Particle Therapy Market Overview
• 9.2. China Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Particle Therapy Market

• 10.1. India Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Particle Therapy Market

• 11.1. Japan Particle Therapy Market Overview
• 11.2. Japan Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Particle Therapy Market

• 12.1. Australia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Particle Therapy Market

• 13.1. Indonesia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Particle Therapy Market

• 14.1. South Korea Particle Therapy Market Overview
• 14.2. South Korea Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Particle Therapy Market

• 15.1. Western Europe Particle Therapy Market Overview
• 15.2. Western Europe Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Particle Therapy Market

• 16.1. UK Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Particle Therapy Market

• 17.1. Germany Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Particle Therapy Market

• 18.1. France Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Particle Therapy Market

• 19.1. Italy Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Particle Therapy Market

• 20.1. Spain Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Particle Therapy Market

• 21.1. Eastern Europe Particle Therapy Market Overview
• 21.2. Eastern Europe Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Particle Therapy Market

• 22.1. Russia Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Particle Therapy Market

• 23.1. North America Particle Therapy Market Overview
• 23.2. North America Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Particle Therapy Market

• 24.1. USA Particle Therapy Market Overview
• 24.2. USA Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Particle Therapy Market

• 25.1. Canada Particle Therapy Market Overview
• 25.2. Canada Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Particle Therapy Market

• 26.1. South America Particle Therapy Market Overview
• 26.2. South America Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Particle Therapy Market

• 27.1. Brazil Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Particle Therapy Market

• 28.1. Middle East Particle Therapy Market Overview
• 28.2. Middle East Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Particle Therapy Market

• 29.1. Africa Particle Therapy Market Overview
• 29.2. Africa Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Particle Therapy Market, Segmentation By System, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Particle Therapy Market Competitive Landscape And Company Profiles

• 30.1. Particle Therapy Market Competitive Landscape
• 30.2. Particle Therapy Market Company Profiles
  • 30.2.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Mitsubishi Electric Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Koninklijke Philips N.V Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis

31. Particle Therapy Market Other Major And Innovative Companies

• 31.1. Sumitomo Heavy Industries Ltd.
• 31.2. Varian Medical Systems Inc.
• 31.3. Elekta AB
• 31.4. Shinva Medical Instrument Co. Ltd.
• 31.5. Toshiba Medical Systems Corporation
• 31.6. Brainlab AG
• 31.7. Accuray Incorporated
• 31.8. IBA Worldwide
• 31.9. Mevion Medical Systems Inc.
• 31.10. Avante Health Solutions
• 31.11. Provision Healthcare LLC
• 31.12. ViewRay
• 31.13. Panacea Biotec Ltd.
• 31.14. PTW Freiburg GmbH.
• 31.15. ProNova Solutions LLC

32. Global Particle Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Particle Therapy Market

34. Recent Developments In The Particle Therapy Market

35. Particle Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Particle Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Particle Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Particle Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer